Brita Belli
@britabelli.bsky.social
Nerd translator. Senior Comms at Recursion. Previously at Yale. Author of The Autism Puzzle. Fiction writer & fitness lover. #techbio
Last week, we gathered at The Explorer's Club
in NYC for the first AI Leadership Salon to have a necessary conversation – how are we using AI in ways that support a better future – and what’s next as AI systems move beyond our ability to truly manage them? #AI #TechBio @recursionpharma.bsky.social
in NYC for the first AI Leadership Salon to have a necessary conversation – how are we using AI in ways that support a better future – and what’s next as AI systems move beyond our ability to truly manage them? #AI #TechBio @recursionpharma.bsky.social
October 13, 2025 at 3:19 PM
Last week, we gathered at The Explorer's Club
in NYC for the first AI Leadership Salon to have a necessary conversation – how are we using AI in ways that support a better future – and what’s next as AI systems move beyond our ability to truly manage them? #AI #TechBio @recursionpharma.bsky.social
in NYC for the first AI Leadership Salon to have a necessary conversation – how are we using AI in ways that support a better future – and what’s next as AI systems move beyond our ability to truly manage them? #AI #TechBio @recursionpharma.bsky.social
Had an incredible time at
@recursionpharma.bsky.social's #TechBio Symposium in SLC last week learning about our latest tech breakthroughs and partnership programs & the Recursion approach to drug discovery. Especially loved connecting with my colleagues from across the country & across the pond!
@recursionpharma.bsky.social's #TechBio Symposium in SLC last week learning about our latest tech breakthroughs and partnership programs & the Recursion approach to drug discovery. Especially loved connecting with my colleagues from across the country & across the pond!
September 29, 2025 at 2:26 PM
Had an incredible time at
@recursionpharma.bsky.social's #TechBio Symposium in SLC last week learning about our latest tech breakthroughs and partnership programs & the Recursion approach to drug discovery. Especially loved connecting with my colleagues from across the country & across the pond!
@recursionpharma.bsky.social's #TechBio Symposium in SLC last week learning about our latest tech breakthroughs and partnership programs & the Recursion approach to drug discovery. Especially loved connecting with my colleagues from across the country & across the pond!
🎉 Excited to see that the just-announced $46 billion UK-US Tech Prosperity Deal is putting significant emphasis on AI drug discovery, including: 🧵
September 17, 2025 at 3:11 PM
🎉 Excited to see that the just-announced $46 billion UK-US Tech Prosperity Deal is putting significant emphasis on AI drug discovery, including: 🧵
It's not easy for a reporter to capture the way a company works from the inside - the people driving it, their motivations. It requires access, transparency, & really sharp storytelling skills. All of those came together in this @wired.com feature from Veronique Greenwood.
wired.com/story/artifi...
wired.com/story/artifi...
July 18, 2025 at 3:59 PM
It's not easy for a reporter to capture the way a company works from the inside - the people driving it, their motivations. It requires access, transparency, & really sharp storytelling skills. All of those came together in this @wired.com feature from Veronique Greenwood.
wired.com/story/artifi...
wired.com/story/artifi...
“I’m still the hope guy.”
Two nights ago I had the great privilege of taking my daughters to see @barackobama.bsky.social in conversation with historian Heather Cox Richardson at the Bushnell in Hartford.
He offered a perspective that only he can on the moment we are in. 🧵
Two nights ago I had the great privilege of taking my daughters to see @barackobama.bsky.social in conversation with historian Heather Cox Richardson at the Bushnell in Hartford.
He offered a perspective that only he can on the moment we are in. 🧵
June 19, 2025 at 3:40 PM
“I’m still the hope guy.”
Two nights ago I had the great privilege of taking my daughters to see @barackobama.bsky.social in conversation with historian Heather Cox Richardson at the Bushnell in Hartford.
He offered a perspective that only he can on the moment we are in. 🧵
Two nights ago I had the great privilege of taking my daughters to see @barackobama.bsky.social in conversation with historian Heather Cox Richardson at the Bushnell in Hartford.
He offered a perspective that only he can on the moment we are in. 🧵
Researchers at MIT and @recursionpharma.bsky.social just released the first AI tool to solve protein binding affinity prediction at scale – a major hurdle in drug discovery – and it's completely open source.
www.youtube.com/watch?v=gRtr... #TechBio #openscience 🧪
www.youtube.com/watch?v=gRtr... #TechBio #openscience 🧪
New Open Source Model from MIT & Recursion Solves Major Hurdle in AI Drug Discovery
YouTube video by Recursion
www.youtube.com
June 6, 2025 at 4:37 PM
Researchers at MIT and @recursionpharma.bsky.social just released the first AI tool to solve protein binding affinity prediction at scale – a major hurdle in drug discovery – and it's completely open source.
www.youtube.com/watch?v=gRtr... #TechBio #openscience 🧪
www.youtube.com/watch?v=gRtr... #TechBio #openscience 🧪
🚀 5 open science initiatives that are driving new discoveries.
A number of big pharma, academic research groups & #TechBio companies are providing open source tools, data, and software to drive new discoveries that can lead to new cures.
💥 Here are 5 efforts making an impact. 🧪🧵
A number of big pharma, academic research groups & #TechBio companies are providing open source tools, data, and software to drive new discoveries that can lead to new cures.
💥 Here are 5 efforts making an impact. 🧪🧵
June 6, 2025 at 10:38 AM
🚀 5 open science initiatives that are driving new discoveries.
A number of big pharma, academic research groups & #TechBio companies are providing open source tools, data, and software to drive new discoveries that can lead to new cures.
💥 Here are 5 efforts making an impact. 🧪🧵
A number of big pharma, academic research groups & #TechBio companies are providing open source tools, data, and software to drive new discoveries that can lead to new cures.
💥 Here are 5 efforts making an impact. 🧪🧵
Public datasets fall short when it comes to reliably training AI models for drug discovery. In a new blog, I share how @recursionpharma.bsky.social is helping to fill the gap by providing open source versions of its massive, proprietary cellular screening datasets. www.recursion.com/news/acceler...
Accelerating AI Drug Discovery with Open Source Datasets
www.recursion.com
June 2, 2025 at 2:25 PM
Public datasets fall short when it comes to reliably training AI models for drug discovery. In a new blog, I share how @recursionpharma.bsky.social is helping to fill the gap by providing open source versions of its massive, proprietary cellular screening datasets. www.recursion.com/news/acceler...
🏆 Science deserves to be celebrated.
A recent story by Ian Sample in @theguardian.com details the fascinating life of David R. Liu, a professor at the @broadinstitute.org of MIT & Harvard and one of the winners of the $3m Breakthrough Prize for Life Sciences, known as the “Oscars of Science.” 🧪🧵
A recent story by Ian Sample in @theguardian.com details the fascinating life of David R. Liu, a professor at the @broadinstitute.org of MIT & Harvard and one of the winners of the $3m Breakthrough Prize for Life Sciences, known as the “Oscars of Science.” 🧪🧵
May 6, 2025 at 11:48 AM
🏆 Science deserves to be celebrated.
A recent story by Ian Sample in @theguardian.com details the fascinating life of David R. Liu, a professor at the @broadinstitute.org of MIT & Harvard and one of the winners of the $3m Breakthrough Prize for Life Sciences, known as the “Oscars of Science.” 🧪🧵
A recent story by Ian Sample in @theguardian.com details the fascinating life of David R. Liu, a professor at the @broadinstitute.org of MIT & Harvard and one of the winners of the $3m Breakthrough Prize for Life Sciences, known as the “Oscars of Science.” 🧪🧵
I dove pretty deep into the autism-environmental toxin connection. There's compelling science behind it -- even more so now then when I wrote The Autism Puzzle -- and I'm glad to see it getting more public attention. #autism #ASD www.sevenstories.com/books/3571-t... 🧪
The Autism Puzzle
Paperback edition features a foreword by Caroline Cox, Research Director from the Center for Environmental Health, and a new preface updating the first edition.
www.sevenstories.com
April 22, 2025 at 1:05 AM
I dove pretty deep into the autism-environmental toxin connection. There's compelling science behind it -- even more so now then when I wrote The Autism Puzzle -- and I'm glad to see it getting more public attention. #autism #ASD www.sevenstories.com/books/3571-t... 🧪
New story from Erika Fry in @fortune.com on @recursionpharma.bsky.social's long climb to leading #AI drug discovery company. She looks at skepticism head on & details 3 ingredients needed to succeed: massive data, massive computing power & a serious appetite for risk. fortune.com/2025/04/03/r... 🧪
Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market
Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive supercomputer will give it the edge to dominate the sector.
fortune.com
April 3, 2025 at 6:51 PM
New story from Erika Fry in @fortune.com on @recursionpharma.bsky.social's long climb to leading #AI drug discovery company. She looks at skepticism head on & details 3 ingredients needed to succeed: massive data, massive computing power & a serious appetite for risk. fortune.com/2025/04/03/r... 🧪
🧪 I love stories of accidental scientific discovery. (Penicillin! The smallpox vaccine! Insulin!) So I was particularly excited to discover that one of the great scientific breakthroughs of our time – CRISPR-Cas9 gene editing – was the result of a similar kind of fortuitous accident. 🧵
March 26, 2025 at 7:41 PM
🧪 I love stories of accidental scientific discovery. (Penicillin! The smallpox vaccine! Insulin!) So I was particularly excited to discover that one of the great scientific breakthroughs of our time – CRISPR-Cas9 gene editing – was the result of a similar kind of fortuitous accident. 🧵
Today at #NeurIPS I was introduced to game theory for literature, applying LLMs to Romeo & Juliet to crack the code on characters & assess how various decisions they might make will be received, i.e. “future payoff.” To bring mathematical structure to stories & maybe guide real-life decision making.
December 11, 2024 at 5:20 AM
Today at #NeurIPS I was introduced to game theory for literature, applying LLMs to Romeo & Juliet to crack the code on characters & assess how various decisions they might make will be received, i.e. “future payoff.” To bring mathematical structure to stories & maybe guide real-life decision making.
Reposted by Brita Belli
On Mon., Dec. 9 at the @theaacr.bsky.social Special Conference in Cancer Research, CSO David Hallett will present the 1st monotherapy data readouts from the ELUCIDATE PH1/2 trial for REC-617, a potential best-in-class CDK7 inhibitor. On Tues., Dec. 10, 8:30-9am ET we're holding a live update call. 🧵
December 5, 2024 at 3:19 PM
On Mon., Dec. 9 at the @theaacr.bsky.social Special Conference in Cancer Research, CSO David Hallett will present the 1st monotherapy data readouts from the ELUCIDATE PH1/2 trial for REC-617, a potential best-in-class CDK7 inhibitor. On Tues., Dec. 10, 8:30-9am ET we're holding a live update call. 🧵
👀 What will be the biggest stories in #ML to emerge at
@neuripsconf.bsky.social in Vancouver next week? In AI drug discovery: foundation models & agentic systems. I'll be w/
@valenceai.bsky.social & @recursionpharma.bsky.social
- w/ over 12+ accepted papers - who can discuss our breakthroughs!
@neuripsconf.bsky.social in Vancouver next week? In AI drug discovery: foundation models & agentic systems. I'll be w/
@valenceai.bsky.social & @recursionpharma.bsky.social
- w/ over 12+ accepted papers - who can discuss our breakthroughs!
December 3, 2024 at 4:58 PM
👀 What will be the biggest stories in #ML to emerge at
@neuripsconf.bsky.social in Vancouver next week? In AI drug discovery: foundation models & agentic systems. I'll be w/
@valenceai.bsky.social & @recursionpharma.bsky.social
- w/ over 12+ accepted papers - who can discuss our breakthroughs!
@neuripsconf.bsky.social in Vancouver next week? In AI drug discovery: foundation models & agentic systems. I'll be w/
@valenceai.bsky.social & @recursionpharma.bsky.social
- w/ over 12+ accepted papers - who can discuss our breakthroughs!
Heads up that I made a #TechBio feed on @bsky.app -- just use the #TechBio hashtag to be included! bsky.app/profile/did:...
November 22, 2024 at 6:50 PM
Heads up that I made a #TechBio feed on @bsky.app -- just use the #TechBio hashtag to be included! bsky.app/profile/did:...
How a study on whether rats could drive turned into a study on whether rats experience joy in driving. Spoiler alert: they do. www.independent.co.uk/news/science...
Scientists taught rats to drive – now they love getting behind the wheel
Rats’ behaviour offers profound lesson on potential ‘key to a healthy brain’, scientist says
www.independent.co.uk
November 21, 2024 at 12:43 AM
How a study on whether rats could drive turned into a study on whether rats experience joy in driving. Spoiler alert: they do. www.independent.co.uk/news/science...
The Hack Week project that changed the way @recursionpharma.bsky.social images cells — from CellPaint to, now, brightfield microscopy. A fascinating deep dive from @owlposter.bsky.social #techbio
Why Recursion Pharmaceuticals abandoned cell painting for brightfield imaging
www.owlposting.com/p/why-recurs...
After over a decade,Recursion Pharmaceuticals changed its primary assay. Why is that? I answer that question over 5.6k words (26 minutes to read)
first journalism-y piece!
www.owlposting.com/p/why-recurs...
After over a decade,Recursion Pharmaceuticals changed its primary assay. Why is that? I answer that question over 5.6k words (26 minutes to read)
first journalism-y piece!
Why Recursion Pharmaceuticals abandoned cell painting for brightfield imaging
5.7k words, 26 minutes reading time
www.owlposting.com
November 20, 2024 at 3:55 AM
The Hack Week project that changed the way @recursionpharma.bsky.social images cells — from CellPaint to, now, brightfield microscopy. A fascinating deep dive from @owlposter.bsky.social #techbio
Is there an East Coast-West Coast #biotech culture divide? Interesting perspective from @dshaywitz.bsky.social on how Boston leans more biotech & SF leans more AI, building on insights from Chandana Haque, Dir of Altitude Labs @recursionpharma.bsky.social #techbio
timmermanreport.com/2024/11/coas...
timmermanreport.com/2024/11/coas...
Coastal Culture Clash Around AI in Biotech - TimmermanReport.com
“Does the crowd understand? Is it East versus West Or man against man? Can any nation stand alone?” Burning Heart, by Survivor – Rocky IV In national politics, the culture wars may pit the coasts agai...
timmermanreport.com
November 19, 2024 at 3:48 PM
Is there an East Coast-West Coast #biotech culture divide? Interesting perspective from @dshaywitz.bsky.social on how Boston leans more biotech & SF leans more AI, building on insights from Chandana Haque, Dir of Altitude Labs @recursionpharma.bsky.social #techbio
timmermanreport.com/2024/11/coas...
timmermanreport.com/2024/11/coas...
The call is coming. Nov. 20, 7:30am ET, tune in live to hear what’s next for AI drug discovery after @recursionpharma.bsky.social & Exscientia officially combine to form one leading TechBio powerhouse. Join the livestream on YouTube here: m.youtube.com/channel/UCXZ... #techbio
November 19, 2024 at 12:38 PM
The call is coming. Nov. 20, 7:30am ET, tune in live to hear what’s next for AI drug discovery after @recursionpharma.bsky.social & Exscientia officially combine to form one leading TechBio powerhouse. Join the livestream on YouTube here: m.youtube.com/channel/UCXZ... #techbio
Love coming back to Utah. Bring on the snow!
November 18, 2024 at 4:09 PM
Love coming back to Utah. Bring on the snow!
In a new blog, I share the story of MolE — a foundation model for #chemistry just published in Nature. MolE was trained on ~842 million molecules in a self-supervised manner & fine-tuned on downstream ADMET tasks, ranking 1st in 10 of 22 tasks. communities.springernature.com/posts/introd...
Introducing MolE: A New Model for Predicting Molecular Properties for AI Drug Design and Beyond
communities.springernature.com
November 17, 2024 at 7:48 PM
In a new blog, I share the story of MolE — a foundation model for #chemistry just published in Nature. MolE was trained on ~842 million molecules in a self-supervised manner & fine-tuned on downstream ADMET tasks, ranking 1st in 10 of 22 tasks. communities.springernature.com/posts/introd...